PharmaShots | Incisive News in 3 Shots

Subscribe Now

Waldenstrom Macroglobulinemia

BeiGene's Brukinsa (zanubrutinib) Receives Health Canada's Approval for Waldenström's Macroglobulinemia

BeiGene's Brukinsa (zanubrutinib) Receives Health Canada's Approval for Waldenström's Macroglobulinemia

March 3, 2021

BeiGene Report Results of Brukinsa (zanubrutinib) in P-III ASPEN Study for Waldenström's Macroglobulinemia

BeiGene Report Results of Brukinsa (zanubrutinib) in P-III ASPEN Study for Waldenström's Macroglobulinemia

December 17, 2019

ONO Reports Submission of MAA to MHLW for Tirabrutinib Hydrochloride to Treat Waldenstrom Macroglobulinemia and Lymphoplasmacytic Lymphoma

ONO Reports Submission of MAA to MHLW for Tirabrutinib Hydrochloride to Treat Waldenstrom Macroglobulinemia and Lymphoplasmacytic...

November 29, 2019

Janssen's Imbruvica (ibrutinib) Receives CHMP Positive Recommendation for its Expanded Use in Chronic Lymphocytic Leukaemia and Waldenstrom's Macroglobulinemia in Europe

Janssen's Imbruvica (ibrutinib) Receives CHMP Positive Recommendation for its Expanded Use in Chronic Lymphocytic Leukaemia and Wa...

July 1, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us